miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-07
DOI
10.1038/srep32541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway
- (2016) FANG WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- MiR-564 functions as a tumor suppressor in human lung cancer by targeting ZIC3
- (2015) Bin Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- KEGG as a reference resource for gene and protein annotation
- (2015) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- ErbB2-intronic MicroRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling
- (2015) D C Schmitt et al. Cell Death & Disease
- Non-mutational (epigenomic) structural variation in the transcriptome of cancer cells
- (2015) E. Aubrey Thompson Oncotarget
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- miR-34: from bench to bedside
- (2015) Massimiliano Agostini et al. Oncotarget
- Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer
- (2014) C. Geng et al. CANCER RESEARCH
- Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors
- (2014) Ozgur Sahin et al. CELL RESEARCH
- MicroRNAs: master regulators of drug resistance, stemness, and metastasis
- (2014) Umar Raza et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer
- (2014) Aoife Ward et al. JOURNAL OF PATHOLOGY
- MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer
- (2014) WEI WANG et al. ONCOLOGY REPORTS
- Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control
- (2013) Emanuele de Rinaldis et al. BMC GENOMICS
- Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
- (2013) Howard A. Burris CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types
- (2013) Carolyn D. Britten CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways
- (2013) Longlong Bao et al. CANCER LETTERS
- Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
- (2013) Kamal S. Saini et al. CANCER TREATMENT REVIEWS
- Acquisition of epithelial–mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway
- (2013) Hao Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells
- (2013) Yannick D. Benoit et al. EXPERIMENTAL CELL RESEARCH
- A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells
- (2013) Daya Luo et al. Journal of Translational Medicine
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
- (2013) Maria D. Paraskevopoulou et al. NUCLEIC ACIDS RESEARCH
- Integration of molecular targeted therapy with radiation in head and neck cancer
- (2013) Yu Du et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic and Predictive Significance of MYC and KRAS Alterations in Breast Cancer from Women Treated with Neoadjuvant Chemotherapy
- (2013) Cynthia Brito Lins Pereira et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- A Cell of Origin Gene Signature Indicates Human Bladder Cancer Has Distinct Cellular Progenitors
- (2013) Garrett M. Dancik et al. STEM CELLS
- Role of PRAS40 in Akt and mTOR signaling in health and disease
- (2012) Claudia Wiza et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer
- (2012) Q. Wang et al. CANCER RESEARCH
- The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
- (2012) T. Shimizu et al. CLINICAL CANCER RESEARCH
- miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours
- (2012) Francesca Biagioni et al. EMBO Molecular Medicine
- MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma
- (2012) YuXiang Fang et al. HEPATOLOGY
- EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial–Mesenchymal Transition and anoikis in colon cancer cells
- (2012) Angelo Ferraro et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma
- (2012) Yasushi Iida INTERNATIONAL JOURNAL OF ONCOLOGY
- Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer
- (2012) Stefan Uhlmann et al. Molecular Systems Biology
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers
- (2012) Sohrab P. Shah et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells
- (2012) Oshrat Hershkovitz Rokah et al. PLoS One
- A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1
- (2012) Qing Xu et al. Journal of Molecular Cell Biology
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Genomic Determinants of PI3K Pathway Inhibitor Response in Cancer
- (2012) Britta Weigelt et al. Frontiers in Oncology
- mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways
- (2011) P. Gulhati et al. CANCER RESEARCH
- microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
- (2011) F. M. Buffa et al. CANCER RESEARCH
- miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes
- (2011) Harsh Dweep et al. JOURNAL OF BIOMEDICAL INFORMATICS
- MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F
- (2011) S. Jurmeister et al. MOLECULAR AND CELLULAR BIOLOGY
- BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study
- (2011) Eleni Makrodouli et al. Molecular Cancer
- PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
- (2011) V Serra et al. ONCOGENE
- miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
- (2011) Espen Enerly et al. PLoS One
- MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia
- (2011) Chi-Yu Lai et al. PLoS One
- Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer
- (2010) Alfonso Sánchez-Muñoz et al. BMC CANCER
- A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
- (2010) Ankur K. Nagaraja et al. MOLECULAR ENDOCRINOLOGY
- miRBase: integrating microRNA annotation and deep-sequencing data
- (2010) A. Kozomara et al. NUCLEIC ACIDS RESEARCH
- Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance
- (2009) Özgür Sahin et al. BMC Systems Biology
- In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
- (2009) K. P. Hoeflich et al. CLINICAL CANCER RESEARCH
- The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
- (2009) Li-Bing Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels
- (2008) D. Morishita et al. CANCER RESEARCH
- Epithelial mesenchymal transition traits in human breast cancer cell lines
- (2008) T. Blick et al. CLINICAL & EXPERIMENTAL METASTASIS
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
- (2008) Arkaitz Carracedo et al. JOURNAL OF CLINICAL INVESTIGATION
- Endogenous human microRNAs that suppress breast cancer metastasis
- (2008) Sohail F. Tavazoie et al. NATURE
- The PTEN–PI3K pathway: of feedbacks and cross-talks
- (2008) A Carracedo et al. ONCOGENE
- Class I PI3K in oncogenic cellular transformation
- (2008) L Zhao et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started